We chose to investigate KAT2A further because this gene is essential to three of the five AML cell lines studied (MOLM-13, OCI-AML2, and OCI-AML3), and as such may be relevant to a wider group of AML patients. This evidence concerns the gene RUNX3 and acute myeloid leukemia.